Device Trial Radar · NCT06685133
Prospective Evaluation of the Tool-in-lesion Technology of the Galaxy System in Routine Clinical Practice
Last checked: Nov 20, 2026Latest source record: Aug 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Nov 8, 2024
Primary completion
Oct 30, 2025
Study completion Oct 30, 2027
Sponsor
- Lead sponsor
- Noah MedicalNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 12, 2024
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A prospective observational study evaluating the accuracy of the tool-in-lesion technology of the Galaxy SystemTM in normal clinical practice.
Conditions
- Lung Cancer
- Lung; Nodule
Interventions
Robotic assisted bronchoscopyDevice
Subjects will undergo a robotic navigated bronchoscopy to biopsy peripheral pulmonary nodules.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Successful Navigation to the lesionTime frame: During the procedure
2 more outcomes with a free account
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
CHI Memorial Hospital
Chattanooga, Tennessee
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.